Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S0140-6736(19)31914-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA): a prospective, open-label, non-inferiority, randomised extension study.
Lancet Diabetes Endocrinol
April 2024
General and Endocrine Surgery, Université de Lille, Inserm U1190, Centre Hospitalier et Universitaire de Lille, Institut Pasteur de Lille, Lille, France.
Background: The multicentre randomised trial YOMEGA (NCT02139813) comparing the one anastomosis gastric bypass (OAGB) with the Roux-en-Y gastric bypass (RYGB) confirmed the non-inferiority of OAGB on weight loss outcomes at 24 months. We aimed to report weight loss, metabolic, and safety outcomes at 5 years.
Methods: YOMEGA is a prospective, open-label, non-inferiority, randomised trial conducted at nine centres in France.
The YOMEGA non-inferiority trial.
Lancet
October 2019
Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy. Electronic address:
The YOMEGA non-inferiority trial - Authors' reply.
Lancet
October 2019
Department of Endocrinology, Diabetology and Nutrition, Specialized Center for Obesity Management, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France; CarMeN Laboratory, INSERM 1060, Lyon, France; Université Claude Bernard Lyon 1, Lyon, France.
The YOMEGA non-inferiority trial.
Lancet
October 2019
Rennes 1 University, Rennes, France; Institut national de la santé et de la recherche médicale INSERM, Rennes, France.
The YOMEGA non-inferiority trial.
Lancet
October 2019
El Fara Clinic, Department of Surgery, Masjed Al Takwa 7, Al Ain, United Arab Emirates. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!